Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia
The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Familial platelet disorder with predisposition to acute myelogenous leukaemia (FPD/AML, MIM 601399) is an autosomal dominant disorder characterized by qualitative and quantitative platelet defects, and propensity to develop acute myelogenous leukaemia (AML). Informative recombination events in 6 FPD/AML pedigrees with evidence of linkage to markers on chromosome 21q identified an 880-kb interval containing the disease gene. Mutational analysis of regional candidate genes showed nonsense mutations or intragenic deletion of one allele of the haematopoietic transcription factor CBFA2 (formerly AML1) that co-segregated with the disease in four FPD/AML pedigrees. We identified heterozygous CBFA2 missense mutations that co-segregated with the disease in the remaining two FPD/AML pedigrees at phylogenetically conserved amino acids R166 and R201, respectively. Analysis of bone marrow or peripheral blood cells from affected FPD/AML individuals showed a decrement in megakaryocyte colony formation, demonstrating that CBFA2 dosage affects megakaryopoiesis. Our findings support a model for FPD/AML in which haploinsufficiency of CBFA2 causes an autosomal dominant congenital platelet defect and predisposes to the acquisition of additional mutations that cause leukaemia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The transcription factor RUNX-1 plays a key role in megakaryocyte differentiation and is mutated in cases of myelodysplastic syndrome and leukemia.”
From Differentiation-dependent interactions between RUNX-1 and FLI-1 during megakaryocyte development. (2009) · cites this paper as [48]
In the citing paper
“Germ line mutations in RUNX-1 cause familial platelet disorder with the propensity to develop acute myelogenous leukemia (FPD/AML), a rare autosomal dominant disorder characterized by quantitative and qualitative platelet defects and a high incidence of developing myelodysplastic syndrome (MDS) and leukemia”
From Differentiation-dependent interactions between RUNX-1 and FLI-1 during megakaryocyte development. (2009) · cites this paper as [48]
Citations
Cites
Okuda, T., van Deursen, J., Hiebert, S. W., Grosveld, G., & Downing, J. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80986-1 · Cited by 1,856
de Thé, H., Chomienne, C., Lanotte, M., Degos, L., & Dejean, A. (1990) · Nature · doi:10.1038/347558a0 · Cited by 1,355 · cited 1×
“Fusion of PDGF Receptor β to a novel ETS-like gene, TEL, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation.”
BackgroundWang, Q., Stacy, T., Binder, M., Marin-Padilla, M., Sharpe, A. H., & Speck, N. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3444 · Cited by 1,178
Self-citationGolub, T. R., Barker, G. F., Lovett, M., & Gilliland, D. G. (1994) · Cell · doi:10.1016/0092-8674(94)90322-0 · Cited by 1,155
Self-citationOncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis.
Weinberg, R. A. (1989) · PubMed · Cited by 949
The murine gene p27Kip1 is haplo-insufficient for tumour suppression
Fero, M. L., Randel, E., Gurley, K. E., Roberts, J. M., & Kemp, C. J. (1998) · Nature · doi:10.1038/24179 · Cited by 784
Fusion Between Transcription Factor CBFβ/PEBP2β and a Myosin Heavy Chain in Acute Myeloid Leukemia
Liu, P., Tarlé, S. A., Hajra, A., Claxton, D. F., Marlton, P., Freedman, M., Siciliano, M. J., & Collins, F. S. (1993) · Science · doi:10.1126/science.8351518 · Cited by 732 · cited 1×
“; the CBFB / MYH11 fusion associated with inv(16) myelomonocytic leukaemia with eosinophili”
BackgroundFusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia.
Golub, T. R., Barker, G. F., Bohlander, S. K., Hiebert, S. W., Ward, D. C., Bray-Ward, P., Morgan, E., Raimondi, S. C., Rowley, J. D., & Gilliland, D. G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.4917 · Cited by 704
Self-citationShivdasani, R. A., Rosenblatt, M. F., Zucker-Franklin, D., Jackson, C. W., Hunt, P., Saris, C. J. M., & Orkin, S. H. (1995) · Cell · doi:10.1016/0092-8674(95)90531-6 · Cited by 693 · cited 1×
“It is notable that mice hemizygous for genes required for megakaryopoiesis, such as Gata1 , Nfe2 and fog , have apparent platelet defect”
BackgroundShivdasani, R. A., Fujiwara, Y., McDevitt, M. A., & Orkin, S. H. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3965 · Cited by 674 · cited 1×
“It is notable that mice hemizygous for genes required for megakaryopoiesis, such as Gata1 , Nfe2 and fog , have apparent platelet defect”
Background
Cited by
Items 901–1,000 of 1,000
Wang, S., Chen, W.-L., Wang, Z., Li, X., Lin, S., Gao, C., Huang, Y., Luo, D.-F., Li, J., Zi, Y., et al. (2016) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2016.1160087 · Cited by 2
Karki, N. R., Savage, N. M., & Kutlar, A. (2021) · Case Reports in Oncology · doi:10.1159/000512016 · Cited by 2
Nakano, T. A., & Paola, J. D. (2018) · Pediatric oncology · doi:10.1007/978-3-319-61421-2_11 · Cited by 2
Coiteux, V., Fenwarth, L., Duployez, N., Ainaouï, M., Borel, C., Poloméni, A., Yakoub‐Agha, I., & Chalandon, Y. (2022) · Bulletin du Cancer · doi:10.1016/j.bulcan.2022.09.002 · Cited by 2
Demko, N., & Geyer, J. T. (2024) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.22192 · Cited by 2
LeBlanc, K. (2013) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/m23c7h · Cited by 2
Familiäre lymphatische und myeloische Neoplasien
Siebert, R. (2003) · Springer eBooks · doi:10.1007/978-3-642-59343-7_3 · Cited by 2
Cytogenetic and Molecular Genetic Changes in Childhood Acute Leukaemias
Niini, T. (2002) · Helda - University of Helsinki Institutional Repository · Cited by 2
Cytogenetic abnormalities in myelodysplastic syndromes
Olney, H. J., & Beau, M. M. L. (2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545269.005 · Cited by 2
Lambert, M. P., & Poncz, M. (2007) · Elsevier eBooks · doi:10.1016/b978-012369367-9/50816-8 · Cited by 2
Self-citationTranscription Factors Responsible for Megakaryocyte-specific Gene Expression
Doi, T. (2005) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.125.685 · Cited by 2
Schwab, M. (2005) · Springer eBooks · doi:10.1007/3-540-26616-x_4 · Cited by 2
Fang, S., Botero, J. P., & Hackney, L. R. (2023) · Clinical Case Reports · doi:10.1002/ccr3.7273 · Cited by 1
Zhou, H., Zhao, J., & Gu, X. (2025) · Frontiers in Hematology · doi:10.3389/frhem.2025.1608314 · Cited by 1
RUNX1-FPDMM in families with mild thrombocytopenia and platelet function anomalies: a case series
Glonnegger, H., Boeckelmann, D., Wiedenhoefer, R., Hassenpflug, W.-A., Ripperger, T., Lebrecht, D., Knöfler, R., Tiebel, O., Koehler, U., Wehr, C., et al. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1657054 · Cited by 1
“RUNX1 germline variants, which cause familial platelet disorder with a propensity for myeloid malignancy (RUNX1-FPDMM) (OMIM 601399), were first elucidated in 1999 (7).”
Targeting RUNX1 Germline Variants: Agents Under Investigation
Ghalamkari, S., Hahn, C. N., Lau, A., Scott, H. S., Homan, C. C., & Brown, A. L. (2025) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-025-00767-w · Cited by 1
Moving Beyond Somatic Alterations: Uncovering the Germline Basis of Myeloid Malignancies
Younes, I. E., Nguyen, L., & Zhang, L. (2026) · Cancers · doi:10.3390/cancers18020240 · Cited by 1
Olson, T. S., Ericson, K. R., Antin, J. H., Babbitt, L., Babich, M., Deuitch, N. T., Dinardo, C. D., Ford, P. J., Obeng, E. A., Stewart, B. L., et al. (2026) · Haematologica · doi:10.3324/haematol.2025.300403 · Cited by 1
Menezes, A. C., Deuitch, N. T., Pintuff, A., Zhen, T., Wincovitch, S., Öztürk, K., Carter, H. K., Ripperger, T., Godley, L. A., & Liu, P. (2026) · Blood Advances · doi:10.1182/bloodadvances.2026019984 · Cited by 1
“14 15-17 In 2019, we launched the first longitudinal natural history study of patients with germline RUNX1 variants to better understand FPDMM, 18,19 with the goal of guiding improved clinical care.”
Lineage-Specific Transcription Factor Aberrations in AML
Mueller, B. U., & Pabst, T. (2009) · Cancer treatment and research · doi:10.1007/978-0-387-69259-3_7 · Cited by 3
AML-1 steps up to the platelets
Irvin, B. J., & Hiebert, S. W. (2004) · Nature Medicine · doi:10.1038/nm0304-238 · Cited by 1
Insights in Megakaryopoiesis and Platelet Biogenesis from Studies of Inherited Thrombocytopenias
Freson, K. (2016) · Springer eBooks · doi:10.1007/978-3-319-39562-3_14 · Cited by 1
Gene Regulation of Platelet Function
Gnatenko, D. V., Li, Z., & Bahou, W. F. (2017) · Springer eBooks · doi:10.1007/978-3-319-47462-5_70 · Cited by 1
Kottke‐Marchant, K. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-2606-0.00002-0 · Cited by 1
McMilin, K. D., & Dasgupta, S. (2007) · Stem Cells and Development · doi:10.1089/scd.2006.0080 · Cited by 1
Familial platelet disorder with predisposition to acute myelogenous leukemia (FPD/AML)
Heller, P. (2011) · Atlas of Genetics and Cytogenetics in Oncology and Haematology · doi:10.4267/2042/44528 · Cited by 1
Miller, K. B., & Rozenvald, I. B. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3764-2_25 · Cited by 2
Familiáris myelodysplasiás szindróma és akut myeloid leukaemia klinikai és genetikai háttere
Király, P. A., Kállay, K. M., Marosvári, D., Benyó, G., Szőke, A., Csomor, J., & Bödör, C. (2016) · Orvosi Hetilap · doi:10.1556/650.2016.30375 · Cited by 5
Erblich bedingte Thrombozytopenien
Ballmaier, M., Balduini, C. L., Welte, K., & Germeshausen, M. (2006) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-006-1346-z · Cited by 1
Etiology of Leukemia in Children with Down Syndrome
Xavier, A. C., Ge, Y., & Taub, J. W. (2016) · Springer eBooks · doi:10.1007/978-3-319-05798-9_4 · Cited by 2
Chromosomal Translocations in B-Cell Leukemias and Lymphomas
Look, A. T., & Ferrando, A. A. (2004) · Elsevier eBooks · doi:10.1016/b978-012053641-2/50024-1 · Cited by 2
Mecucci, C., Battista, V. D., & Nofrini, V. (2016) · Wiley eBooks · doi:10.1002/9781118527948.ch1 · Cited by 1
When Should Congenital Inherited Thrombocytopenia Be Suspected?
Viallard, J., & Nurden, P. (2007) · European Oncology & Haematology · doi:10.17925/eoh.2007.0.0.23 · Cited by 1
Megakaryocytic Transcription Factors in Disease and Leukemia
Cantor, A. B. (2016) · Springer eBooks · doi:10.1007/978-3-319-39562-3_3 · Cited by 1
Next-Generation Sequencing in the Study of Platelets
Leo, V. (2017) · Springer eBooks · doi:10.1007/978-3-319-47462-5_47 · Cited by 1
Myelodysplastic Syndromes and Myeloproliferative Neoplasms in Children
Smith, F. O., Dvorak, C. C., & Braun, B. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35762-3.00063-9 · Cited by 1
Diagnosis and Treatment of Childhood Acute Myeloid Leukemia
Sweetser, D. A., & Weinstein, H. J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3764-2_21 · Cited by 1
NOTCHing down a win for megakaryocytes
Taoudi, S. (2018) · Blood · doi:10.1182/blood-2017-11-815464 · Cited by 1
Familial Leukemia Associated with Thrombocytopenia
Trizuljak, J., & Doubek, M. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.85303 · Cited by 1
“For the first time, germline RUNX1 mutations were described in 1999 [8].”
BackgroundErdomaeva, Y. A., Федорова, Д. В., Zharkov, P. А., Kurnikova, М. А., Mann, S. G., & Raykina, E. V. (2019) · Pediatric Hematology/Oncology and Immunopathology · doi:10.24287/1726-1708-2019-18-3-54-61 · Cited by 1
“RUNX1 FLI1 RUNX1 FLI1 TRO TRO Вопросы гематологии/онкологии и иммунопатологии в педиатрии 2019 | Том 18 | № 3 | 54‒61 пациентов развился ОМЛ (возраст манифестации – 40–60 лет); у 2,2% – МДС (возраст манифестации – 35–70 лет) и у 1,3% – хронический миелолейкоз (ХМЛ) (возраст манифестации – 30–65 лет).”
InfluentialSteensma, D. P., & Stone, R. M. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-2865-7.00099-0 · Cited by 1
Zhang, R. R., Chen, X. J., Ren, Y. Y., Yang, W. Y., & Zhu, X. F. (2021) · PubMed Central · doi:10.3760/cma.j.issn.0253-2727.2021.04.007 · Cited by 1
“[2] Song WJ, Sullivan MG, Legare RD, et al.”
BackgroundChromosomal Translocations in Leukaemia: Emerging Networks
Bohlander, S. K. (2004) · Springer eBooks · doi:10.1007/978-94-017-1033-6_15 · Cited by 1
Cytogenetic Diagnosis of Myelodysplastic Syndromes
Olney, H. J., & Beau, M. M. L. (2013) · Springer eBooks · doi:10.1007/978-3-642-36229-3_3 · Cited by 2
Lambert, M. P., & Poncz, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813456-6.00046-1 · Cited by 1
Self-citationThe Genetics of Acute Myeloid Leukemias
Owen, C., & Fitzgibbon, J. (2010) · Wiley eBooks · doi:10.1002/9781444318531.ch4 · Cited by 1
Heritable predisposition to childhood hematologic malignancies
Seif, A. E., Lange, B. J., Biegel, J. A., & Nichols, K. E. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511977633.012 · Cited by 1
Molecular Closeness of Zebrafish and Human Platelets
Kaviya, M., Sangeetha, T., Kathirvel, B., Rajesh, M., Vijayarani, K., Issara, U., Balasubramanian, B., & Arumugam, V. A. (2022) · Springer eBooks · doi:10.1007/978-981-19-0817-0_6 · Cited by 1
RUNX1 together with DAT mutations predicted poor outcome in acute myeloid leukemia
Xiao, J., Xie, J., Zhou, B., Liu, Y., Lu, J., Jiang, A., Yao, H., Qiu, Q., Ding, Z., Xue, S., et al. (2023) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2023.2190433 · Cited by 1
Germline Predisposition to Myelodysplastic Syndromes
Gener‐Ricos, G., Gerstein, Y. S., Hammond, D. E., & Dinardo, C. D. (2023) · The Cancer Journal · doi:10.1097/ppo.0000000000000660 · Cited by 1
Germline and somatic drivers in inherited hematologic malignancies
Zoller, J., Trajanova, D., & Feurstein, S. K. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1205855 · Cited by 1
Lorsbach, R. B. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511781292.013 · Cited by 1
Stock, W., & Larson, R. A. (2003) · Springer eBooks · doi:10.1007/978-3-642-55780-4_14 · Cited by 1
Uniparental Disomy in Cancer – A New Tool in Molecular Cancer
Tuna, M., & Amos, C. I. (2010) · Wiley eBooks · doi:10.1002/9780470015902.a0022430 · Cited by 1
Escher, R., Mühlematter, D., Scott, H. S., Jotterand, M., & Tobler, A. (2004) · PubMed · Cited by 1
Mutations in human cancer: how close should we look?
Cammenga, J., & Nimer, S. D. (2002) · Leukemia Research · doi:10.1016/s0145-2126(01)00174-6 · Cited by 1
ABERRANT EPIGENETICS IN THE MOLECULAR PATHOGENESIS OF HUMAN ACUTE MYELOID LEUKEMIA
Scott, S. A. (2005) · University Library - University of Saskatchewan (University of Saskatchewan) · Cited by 1
Molecular mechanisms and gene expression patterns in myelodysplastic syndromes
Hofmann, W., & Koeffler, H. P. (2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545269.006 · Cited by 1
Blood Platelets and von Willebrand Disease
Miller, J. L., & Rao, A. K. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0974-2.00040-3 · Cited by 1
Acute Myeloid Leukemia in Adults: Mast Cell Leukemia and Other Mast Cell Neoplasms
Stone, R. M., & Schiffer, C. A. (2017) · Wiley eBooks · doi:10.1002/9781119000822.hfcm115 · Cited by 1
Olney, H. J., & Beau, M. M. L. (2015) · Wiley eBooks · doi:10.1002/9781118795569.ch7 · Cited by 1
Ito, Y. (2017) · Springer eBooks · doi:10.1007/978-3-319-67199-4_101825 · Cited by 1
RUNX/CBF Transcription Factors
Zhang, D. (2002) · Elsevier eBooks · doi:10.1016/b0-12-227555-1/00178-7 · Cited by 1
Expresión de RUNX1 en células de pacientes pediátricos con leucemia aguda linfoblástica
Montero-Ruíz, O. (2008) · doi:10.24275/uami.7p88cg77z · Cited by 1
Myelodysplasia and Myeloid Proliferations
Singh, Z. N., & Gulley, M. L. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-116-5_4
de Matos, S. S. M. C. (2011) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/gfjt-s686
Treatment, Outcomes, and Challenges of Newly Diagnosed AML in Children and Adolescents
Arceci, R. J. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-322-6_17 · Cited by 1
Parker, J. E. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-322-6_3
Analysis of senescence-like growth arrest induced by RUNX1 and its fusion derived oncoproteins
Wolyniec, K. (2008) · Enlighten: Theses (The University of Glasgow) · doi:10.5525/gla.thesis.578 · Cited by 1
Point Mutations in the AML1/RUNX1 Gene Associated with Myelodysplastic Syndrome(MDS)
Harada, H., Harada, Y., & Kimura, A. (2005) · Acta medica Nagasakiensia · doi:10.11343/amn.50.s91 · Cited by 1
Shared genes in rheumatic diseases, the role of PD1 and the RUNX genes in disease susceptibility
Alarcón-Riquelme, M. E., & Kozyrev, S. V. (2006) · Birkhäuser-Verlag eBooks · doi:10.1007/3-7643-7419-5_6
Prognostic molecular markers of childhood leukemia
Gauffin, F. (2010) · Figshare
Genetic Studies of Acute Lymphoblastic Leukemia
Kuchinskaya, E. (2007) · Figshare · Cited by 1
Unusual Myelodysplastic Syndromes and Myeloproliferative Neoplasms
Padron, E., & Komrokji, R. S. (2012) · Wiley eBooks · doi:10.1002/9781118464557.ch43
The Genetics of Acute Myeloid Leukemias
Gilliland, D. G. (2005) · Wiley eBooks · doi:10.1002/9780470987063.ch4
Self-citationCortés-Lavaud, X., & Odero (2014) · Depósito Académico Digital Universidad de Navarra (University of Navarra)
Menezes, J. (2014) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Genomic characterization of ETV6/RUNX1-positive acute lymphoblastic leukemia
Lilljebjörn, H. (2011) · Lund University Publications (Lund University)
Gene Expression Studies of Hematologic Malignacies
Andersson, A. (2005) · Lund University Publications (Lund University)
Aberrant Transcription Factors in AML
Friedman, A. D. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-322-6_2
Huret, J. L., & Leonard, C. A. (2003) · Leukemia · doi:10.1038/sj.leu.2402984
On Cancer Cell Cycle and Universal Apoptosis Parameters Signaling Unravelled In Silico
Marretta, R. M. A., & Ales, F. (2010) · The Open Conference Proceedings Journal · doi:10.2174/22102892010010100007
Unusual Course of Myelodysplastic Syndrome with Presumed Familial Origin
Bacher, U., Ocheni, S., Schafhausen, P., Oyekunle, A. A., Dierlamm, J., Zander, A. R., Bokemeyer, C., Haferlach, T., & Kröger, N. M. (2011) · Acta Haematologica · doi:10.1159/000330529
Runx1 C-terminal Domains During Hematopoietic Development and Leukemogenesis: A Dissertation
Dowdy, C. R. (2012) · eScholarship@UMassChan · doi:10.13028/2mya-hk98
“Runx1 and CBFbeta are the most common targets of mutation or translocation in human acute myeloid leukemias (AML).88,89 The (8;21) translocation is found in 12-15% of de novo adult AML and is a major contribution to secondary AML in patients who received cytotoxic chemotherapy.88-91 In addition to AML, Runx1 mutations…”
BackgroundInfluentialBain, B. J., Thomas, A. E., Clough, V., Ali, S., Andrews, V., Layton, M., Wong, C., Tawil, A. R. H., & Hiwaizi, F. (2004) · Clinical & Laboratory Haematology · doi:10.1111/j.1365-2257.2004.00625.x
Argl83His, a New Mutational "Hot-Spot" in the Growth Hormone Gene
Wajnrajch, M. P., Gertner, J. M., Mullis, P., Deladoëy, J., Cogan, J. D., Lekhakula, S., Kim, S., Dannies, P. S., Saenger, P. H., Moshang, T., et al. (2000) · International Journal on Disability and Human Development · doi:10.1515/ijdhd.2000.1.3.125
The RUNX1 Transcription Factor: A Gatekeeper in Acute Leukemia
Stocking, C., Niebuhr, B., Fischer, M., Täger, M., & Cammenga, J. (2007) · NATO science for peace and security series. A, Chemistry and biology · doi:10.1007/978-1-4020-6469-2_14
Genetic and BiologicalDiversity in TEL-AML1 Positive ALL
Stams, W. A. G. (2005) · EUR Research Repository (Erasmus University Rotterdam)
New insights into molecular mechanisms of haematological malignancies
Fey, M. F. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn312
“The same genetic principle also operates in a familial autosomal dominant platelet disorder with predisposition to AML [17].”
BackgroundDOWN SYNDROME AND LEUKEMIA: WHAT HAVE WE LEARNED?
Savaşan, S., & Taub, J. (2000) · Fetal and Pediatric Pathology · doi:10.1080/pdp.19.4.269.281
“The locus for a familial platelet disorder with associated myeloid malignancy has been localized to 21q22 and has now been identi ed as being due to a mutation of the AML1 gene [14, 15].”
BackgroundASH 2009 meeting report—Top 10 clinically oriented abstracts in myelodysplastic syndromes
Steensma, D. P. (2010) · American Journal of Hematology · doi:10.1002/ajh.21629
FAMILIAL ASPECTS OF HAEMATOLOGICAL MALIGNANCY
Carmichael, C., & Scott, H. S. (2007) · Cancer Forum
Rabbolini, D. J., Morel‐Kopp, M., Gabrielli, S., Chen, Q., Stevenson, W. S., & Ward, C. M. (2016) · InTech eBooks · doi:10.5772/61777
Myelodysplastic and Myeloproliferative Diseases in Children: Current Concepts
Vyas, P. (2013) · Pediatric and adolescent medicine · doi:10.1159/000350348
Embryonic Diapause as a Model for Pluripotent Stem Cell Quiescence
Margaretha, L. (2012) · ResearchWorks at the University of Washington (University of Washington)
Regulation of RUNX3 in gastric and breast cancer
Tsang, Y. N. (2012) · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign)
Rôle de deux suppresseurs de tumeurs TET2 et P53 dans un contexte hématopoïétique
Mahfoudhi, E. (2016) · theses.fr (ABES) · doi:10.70675/f4cb068cz8085z4a5az9d43z0a573a109bcb
Metadata
- Authors
- Song, W.-J., Sullivan, M. G., Legare, R. D., Hutchings, S., Tan, X., Kufrin, D., Ratajczak, J., Resende, I. C., Haworth, C., Hock, R., Loh, M., Felix, C., Roy, D.-C., Busque, L., Kurnit, D., Willman, C., Gewirtz, A. M., Speck, N. A., Bushweller, J. H., Li, F. P., Gardiner, K., Poncz, M., Maris, J. M., & Gilliland, D. G.
- Affiliations
- Brigham and Women's Hospital (US)
- Brown University (US)
- University of Pennsylvania (US)
- Leicester Royal Infirmary (GB)
- St Vincent Hospital (US)
- Hôpital Maisonneuve-Rosemont (CA)
- University of Michigan (US)
- University of New Mexico (US)
- Dartmouth College (US)
- University of Virginia (US)
- Harvard University (US)
- Roosevelt Institute (US)
- Corresponding author
- Gilliland, D. Gary
- ORCID
- Venue
- Nature Genetics
- Published
- 1999-10
- Volume
- 23
- Issue
- 2
- Pages
- 166-175
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1739103212
- Cited by
- 1,100
- References
- 49
- Citations by year
- 2026: 9 · 2025: 23 · 2024: 27 · 2023: 32 · 2022: 29 · 2021: 36 · 2020: 46 · 2019: 33 · 2018: 26 · 2017: 61 · 2016: 54 · 2015: 35 · 2014: 30 · 2013: 33 · 2012: 53
- FWCI
- 25.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (7r29ai039536-04)
- National Cancer Institute (R01CA081932, R01-CA78545, R01 CA81932, R01CA078545)
- National Institute of Allergy and Infectious Diseases (R29 AI39536)
- Topics
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Health Sciences › Medicine › Hematology › Blood disorders and treatments
- Keywords
- RUNX1, haploinsufficiency, autosomal dominant inheritance, missense mutations, megakaryopoiesis, megakaryocyte colony formation, platelet disorders, chromosome 21q, nonsense mutation, intragenic deletion
- MeSH terms
- Amino Acid Sequence, Base Sequence, Blood Platelets, Chromosome Mapping, Colony-Forming Units Assay, DNA Mutational Analysis, DNA-Binding Proteins, Family Health, Female, Genotype, Hematopoiesis, Heterozygote, Humans, Male, Megakaryocytes, Molecular Sequence Data, Mutation, Pedigree, Proto-Oncogene Proteins, RNA, Sequence Homology, Nucleic Acid, Thrombocytopenia, Transcription Factors, Leukemia, Myeloid, Acute, Sequence Deletion, Sequence Homology, Amino Acid, In Situ Hybridization, Fluorescence, Microsatellite Repeats, Genetic Predisposition to Disease, Reverse Transcriptase Polymerase Chain Reaction, Core Binding Factor Alpha 2 Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.